Admedes Schuessler (Pforzheim, Germany) has announced plans to open a facility in Livermore, CA, USA. The new plant is the first major investment by a business of its kind in this city located near San Francisco. Because biotech companies tend to cluster, the hope is that others will follow.
“Startups often want to locate near us so it’s easier to get (their companies) going,” remarks Eric Veit, vice president of Admedes. “Maybe we’ll have a new biotech cluster in Livermore.”
The 18-year-old company, which manufactures heart valve cages and vein stents, derives about 85% of its business from the US market. That spurred interest in opening a US-based manufacturing facility, Veit says. In addition, the proximity to Lawrence Livermore and Sandia national laboratories—known hubs for laser technology—makes Livermore a logical location for the company, which uses lasers to cut nitinol and stainless steel for medical devices.